Oncocyte Files Secondary Stock Shelf

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Oncocyte Files Secondary Stock Shelf

, MT Newswires - 1:57 PM ET 3/31/2025 default

01:57 PM EDT, 03/31/2025 (MT Newswires) -- Oncocyte ( OCX ) filed a registration statement Friday for the resale of up to around 10.6 million shares of its common stock by a selling shareholders from time to time.

About 7.5 million shares for resale were issued in a private placement, while around 3.1 million shares are issuable upon the exercise of pre-funded warrants.

The company said it will not receive any proceeds from the sale of the shares.

It will receive the applicable proceeds from the exercise of the pre-funded warrants, if they are exercised for cash, at an exercise price of $0.001 per share. Oncocyte ( OCX ) said it intends to use those proceeds, if any, for general corporate purposes.

Price: 3.04, Change: -0.17, Percent Change: -5.30

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.